Biotech firm poised to expand in Oklahoma City

SensiQ, which recently won a $1.3 million grant from the National Institutes of Health, could also obtain state incentive money by adding more jobs.

Published: Tuesday, October 1, 2013 By: Brianna Bailey Source: The Oklahoman

With the help of a National Institutes of Health grant to develop new drug-discovery instruments and private equity investment, Oklahoma City-based biotech company SensiQ Technologies is poised for expansion.

The company's lab, housed in the Presbyterian Health Foundation Research Park, makes devices to study biomolecular interaction that helps to develop new drugs.

The company recently was awarded Phase 1 funding from the NIH to further its development of technologies that measure drug interactions. The company will receive about $1.3 million through the NIH FastTrack program to help fund the research.


Back to top